G1 Therapeutics, Inc.·4

May 24, 4:41 PM ET

Thomas Monica R. 4

4 · G1 Therapeutics, Inc. · Filed May 24, 2023

Insider Transaction Report

Form 4
Period: 2023-05-22
Thomas Monica R.
General Counsel
Transactions
  • Award

    Stock Options (Right to buy)

    2023-05-22+150,000150,000 total
    Exercise: $2.88Exp: 2033-05-22Common Stock (150,000 underlying)
  • Award

    Common Stock

    2023-05-22+50,00050,176 total
Footnotes (4)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 25% on May 22, 2024 and 25% annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]Represents (i) 176 shares of common stock; and (ii) 50,000 RSUs from award granted on May, 22 2023.
  • [F4]The shares underlying this option vest as to 25% of the shares on May 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Documents

2 files